Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration

Table 1 Clinical characteristics of patients with age-related macular degeneration managed with a 3 + PRN protocol

	PCV group (n = 77)	Non-PCV group (n = 82)	P
Baseline Characteristics
Age, years	65.81 ± 9.63	68.70 ± 8.31	0.155
Sex (Male/Female)	50/27	42/40	0.080
BCVA (ETDRS letters at first visit)	48.78 ± 19.92	48.12 ± 16.75	0.822
SRF (No/Yes)	12/65	23/59	0.058
IRC (No/Yes)	59/18	54/28	0.182
PED (No/Yes)	18/59	37/45	0.011*
VMA (No/Yes)	60/17	62/20	0.985
Anti-VEGF injection, number	5.71 ± 1.90	4.43 ± 2.29	< 0.001*
Follow up data
BCVA gain at 3 M	6.34 ± 14.64	9.91 ± 15.66	0.102
BCVA gain at 12 M	4.42 ± 20.83	9.37 ± 17.05	0.206

SRF Subretinal fluid, IRC Inner retinal cyst, PED Pigment epithelial detachment, VMA Vitreomacular adhesion, PCV Polypoidal choroidal vasculopathy, VEGF Vascular endothelial growth factor, BCVA Best-corrected visual acuity, BCVA gain at 3 M BCVA changes at three months after treatment and baseline, BCVA gain at 12 M BCVA changes at twelve months after treatment and baseline, M Month
^*P < 0.05 was set as statistical significance

ISSN: 1471-2415